Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis

Identification and optimization of critical process parameters for the production of NOMV vaccine against Neisseria meningitidis

(2012) Bas van de Waterbeemd et al.   VACCINE

Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease

(2012) Patricia Kaaijk et al.   VACCINE

Outer Membrane Vesicles Induce Immune Responses to Virulence Proteins and Protect against Colonization by Enterotoxigenic Escherichia coli

(2011) Koushik Roy et al.   Clinical and Vaccine Immunology

Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles

(2011) Xilian Bai et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Meningococcal serogroup B vaccines: will they live up to expectations?

(2011) Wendell D Zollinger et al.   Expert Review of Vaccines

Next-generation outer membrane vesicle vaccines againstNeisseria meningitidisbased on nontoxic LPS mutants

(2011) Peter van der Ley et al.   Human vaccines & immunotherapeutics

Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys

(2011) Oliver Koeberling et al.   VACCINE

A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection

(2011) Wildaliz Nieves et al.   VACCINE

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii

(2011) Michael J. McConnell et al.   VACCINE

Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development

(2011) Rolando Pajon et al.   PLoS Neglected Tropical Diseases

Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles

(2010) Adam Kulp et al.   Annual Review of Microbiology

Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy

(2010) Jamie Findlow et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and protective efficacy of Vibrio cholerae  outer membrane vesicles in rabbit model

(2010) Nivedita Roy et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Lipoproteins of Bacterial Pathogens

(2010) A. Kovacs-Simon et al.   INFECTION AND IMMUNITY

Proteomic Characterization and Functional Analysis of Outer Membrane Vesicles of Francisella novicida Suggests Possible Role in Virulence and Use as a Vaccine

(2010) Tony Pierson et al.   JOURNAL OF PROTEOME RESEARCH

Delivery of foreign antigens by engineered outer membrane vesicle vaccines

(2010) D. J. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process

(2010) Bas van de Waterbeemd et al.   VACCINE

Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response

(2009) V. Weynants et al.   INFECTION AND IMMUNITY

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

(2009) Johan Holst et al.   VACCINE

ModelingNeisseria meningitidisB metabolism at different specific growth rates

(2008) Gino J.E. Baart et al.   BIOTECHNOLOGY AND BIOENGINEERING

Outer membrane vesicles as acellular vaccine against pertussis

(2008) Roy Roberts et al.   VACCINE